BioAge Labs (BIOA) Total Debt (2023 - 2026)

BioAge Labs has disclosed Total Debt across 4 years of filings, most recently posting $1.2 million for Q1 2026.

• In Q1 2026, Total Debt fell 83.57% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 83.57% YoY), while the FY2025 annual figure was $2.6 million, down 68.85% from the prior year.
• Total Debt came in at $1.2 million for Q1 2026 at BioAge Labs, down from $2.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $14.2 million in Q4 2023 to a low of $1.2 million in Q1 2026.
• Average Total Debt over 4 years is $6.7 million, with a median of $6.3 million recorded in 2025.
• Year-over-year, Total Debt tumbled 40.13% in 2024 and plunged 83.57% in 2026.
• Over 4 years, Total Debt stood at $14.2 million in 2023, then plunged by 40.13% to $8.5 million in 2024, then tumbled by 68.85% to $2.6 million in 2025, then slumped by 56.23% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $1.2 million in Q1 2026, $2.6 million in Q4 2025, and $4.1 million in Q3 2025.